Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people do experience dizziness or fainting on Wegovy (semaglutide), particularly in the early weeks of treatment. It is not listed as a common side effect in the prescribing information, but it can happen — usually linked to dehydration, low blood pressure on standing, or reduced food and fluid intake as appetite falls. This is a prescription-only medicine, and a prescriber should know if you are experiencing episodes of lightheadedness or loss of consciousness while on treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Fainting has several possible explanations during Wegovy treatment, and identifying the pattern helps you and your prescriber respond correctly. The most common cause is orthostatic hypotension, a drop in blood pressure when you move from sitting or lying down to standing. Semaglutide slows gastric emptying and tends to reduce appetite quite sharply, particularly after a dose increase. If you are eating and drinking less than usual, your circulating blood volume falls, and a quick change of posture can tip you into brief unconsciousness or near-fainting.
A second route is straightforward dehydration. Nausea and vomiting (recognised side effects of semaglutide, detailed on the semaglutide overview) reduce both appetite and thirst. Losing fluid without replacing it compounds any tendency to low blood pressure. The guidance on managing GI symptoms on Wegovy covers some practical steps for staying hydrated through the trickier early weeks.
Low blood sugar is less common unless you are also taking medicines that lower glucose (such as sulphonylureas or insulin), but it can mimic fainting. Finally, pre-existing heart-rhythm conditions or vasovagal responses (the kind triggered by pain or anxiety) are not caused by semaglutide but may surface during any period of physical change. Your prescriber needs the full picture before deciding the next step.
Episodes tend to cluster in two windows. The first is the opening weeks of treatment, when your body is adjusting to reduced food intake and the GI effects are at their peak. If you feel faint during this period, the cause is usually dehydration or postural blood pressure change rather than anything more serious, though that distinction needs a clinician to confirm, not a web page.
The second higher-risk window is immediately after each dose increase. Wegovy's titration schedule steps the dose upward roughly every four weeks, and each step can briefly intensify nausea and appetite suppression. Patients sometimes tell our prescribers that they felt fine on their previous dose, then had a dizzy spell in the first few days of a new pen. That pattern fits the dehydration picture well.
If you are new to Wegovy and want to know what the first few weeks typically look like, the guide to starting Wegovy walks through what to expect across the early titration period. And if you have questions about a specific dose, the 3.4mg semaglutide dose page covers one of the most commonly queried steps.
Time of day also matters. Standing up quickly first thing in the morning (before eating or drinking) is a well-known trigger for postural dizziness, particularly if appetite suppression has already reduced overnight fluid intake. Getting up slowly, having a glass of water before getting out of bed, and avoiding long gaps between any food or fluid can all reduce the likelihood of an episode.
If you take antihypertensives (blood pressure medicines), the combination with semaglutide-driven weight loss deserves particular attention. As body weight falls, blood pressure often falls too, and a dose of antihypertensive that was appropriate at your previous weight may produce hypotension at a lower one. That can cause fainting without semaglutide itself being the direct culprit. Your GP or prescriber should review your blood pressure medicines periodically once you are on treatment.
Diuretics carry a similar caution: they reduce fluid volume, and if nausea is already cutting your intake, the combination can push blood pressure lower than expected. The full Wegovy treatment overview outlines the range of factors that a prescriber considers before and during treatment, including concurrent medicines. The NHS also summarises interactions and contraindications for semaglutide on its semaglutide medicines page.
Always give your prescriber a complete and current medicine list. That includes over-the-counter products and supplements, because some affect blood pressure or fluid balance in ways that compound the risk.
Most dizziness on Wegovy is transient and positional. Fainting that is brief, follows standing quickly, and resolves within seconds or a minute, usually fits the orthostatic pattern described above. Keep a brief note on your phone of when episodes happen, what you had eaten or drunk, and what position you were in, that information helps a clinician considerably.
Seek urgent medical help if you experience any of the following: loss of consciousness that lasted more than a minute or two, fainting accompanied by chest pain or palpitations, repeated episodes that are not linked to dehydration or posture, or a fall that caused injury. These warrant assessment the same day. If you are also experiencing severe and persistent abdominal pain, particularly pain that spreads to your back, contact a doctor promptly, the MHRA has highlighted acute pancreatitis as a known though infrequent risk with GLP-1 medicines, and its symptoms can overlap with general unwellness that patients sometimes attribute to other causes.
You can report any suspected side effect, including fainting, through the MHRA's Yellow Card scheme, the service exists precisely to track real-world safety signals from medicines like this one. If your episodes are ongoing and you have concerns about your current treatment plan, the team at nume's aftercare support is available seven days a week. For broader questions about Wegovy and GI-related effects, the page on Wegovy and bloating and the guide to Wegovy and wind address common GI symptoms that often accompany early treatment.
If you are considering whether Wegovy is right for you, a private consultation means a real clinician reviews your health history and full medicine list before any prescription is issued. You can check your eligibility and start a free consultation at any point, no waiting list, reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.